Keywords
hospital records
Epidemiology
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To trace the epidemiological profile of thyroid cancer cases in the North region informed by the Hospital Cancer Records (RHCs) between the years 2000 to 2020. Methods: This is a descriptive epidemiological study, carried out through secondary data, which presented the North region as the unit of analysis. The variables analyzed were: gender, age group, race, federative unit of residence of the case, most important basis of the diagnosis, histological type, diagnosis and previous treatment. Results: 3598 cases of thyroid cancer were reported during the study period, of which 43.13% occurred in the state of Pará. The year with the highest number of consultations and diagnoses was 2018, with 370 and 350 cases, respectively. The profile of the individuals followed the following pattern: female gender (84.26%), brown race (63.03%), aged between 40 and 59 years (44.69%), incomplete primary education (30.54%), microscopic confirmation (97.93), surgery as the main therapeutic protocol (30.21%) and papillary adenocarcinoma as the main histological type (42.05%). Conclusion: By providing knowledge about the profile of the affected population, this study enables the implementation of strategies for the prevention and control of the disease in the region.
References
BORGES AK DA M, et al. Câncer de tireoide no Brasil: estudo descritivo dos casos informados pelos registros hospitalares de câncer, 2000-2016. Epidemiologia e Serviços de Saúde, 2020; 29.
BUSHNIK T e EVANS WK. Sociodemographic characteristics associated with thyroid cancer risk in Canada. Health Reports, 2018; 29(10): 3-11.
BRASIL. Lei no 12.732, de 22 de novembro de 2012. Dispõe sobre o primeiro tratamento de paciente com neoplasia maligna comprovada e estabelece prazo para seu início. Diário Oficial da União. 2012.
BRASIL. Ministério da Saúde. 2018.Câncer de tireoide. Disponível em: https://www.gov.br/inca/pt-br/assuntos/cancer/tipos/tireoide. Acessado em: 18 de janeiro de 2023.
BRASIL. Ministério da Saúde. 2023. Câncer de tireoide. Disponível em: https://www.gov.br/inca/pt-br/assuntos/cancer/tipos/tireoide. Acessado em: 18 de janeiro de 2023.
BRAY F, et al. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin., 2018; 68(6): 394–424.
CIBAS ES e ALI SZ. O Sistema Bethesda 2017 para Relatórios de Citopatologia da Tireoide. Tireoide, 2017; 27(11): 1341-1346.
COOPER DS, et al. Diretrizes revisadas de manejo da American Thyroid Association para pacientes com nódulos de tireoide e câncer diferenciado de tireoide: Grupo de trabalho de diretrizes da American Thyroid Association (ATA) sobre nódulos de tireoide e câncer diferenciado de tireoide. Tireoide, 2009; 19: 1167–1214.
CUBERO AC e GONZÁLEZ MA. Factores de riesgo para cáncer de tiroides. Estudio de casos y controles. Horizonte sanitario, 2019; 18(2): 167–75.
DOS SANTOS LMS. Evolução temporal da mortalidade por câncer de tireoide no Brasil no período de 2000 a 2012. Brazilian Journal of Clinical Analysis, 2016; 48(2): 133–7.
FONSECA ACM, et al. Barreiras de acesso ao tratamento do câncer de tireoide no Sistema Único de Saúde (SUS) brasileiro. Revista de Saúde Pública, 2017; 51(0): 1s–8s.
HAUGEN BR, et al. American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid, 2016; 26(1): 1-133.
IBRAHIM EY e BUSAIDY NL. Treatment and surveillance of advanced, metastatic iodine-resistant differentiated thyroid cancer. Current opinion in oncology, 2017; 29(2): 151-158.
INCA. Coordenação de Prevenção e Vigilância. Estimativa. 2020 - Incidência de câncer no Brasil. Rio de Janeiro: Instituto Nacional de Câncer José Alencar Gomes da Silva, 2019. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//estimativa-2020-incidencia-de-cancer-no-brasil.pdf. Acessado em: 07 de janeiro de 2023.
INFORMAÇÕES do registro hospitalar de câncer - Tabulador Hospitalar. Disponível em: https://irhc.inca.gov.br/RHCNet/visualizaTabNetExterno.action. Acessado em: 13 de janeiro de 2023.
INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATÍSTICA. Cidades e Estados. Disponível em: https://www.ibge.gov.br/cidades-e-estados/pa/.html. Acessado em: 19 de janeiro de 2023.
INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATÍSTICA. Distribuição Espacial da População Segundo Cor ou Raça – Pretos e Pardos. Disponível em: https://www.ibge.gov.br/geociencias/cartas-e-mapas/sociedade-e-economia/15963-distribuicao-espacial-da-populacao-segundo-cor-ou-raca-pretos-e-pardos.html?edicao=16125&t=acesso-ao-produto. Acessado em: 19 de janeiro de 2023.
JEMAL A, et al. Global cancer statistics. CA: a cancer journal for clinicians, 2011; 61(2): 69–90.
KIM J, et al. Geographic influences in the global rise of thyroid cancer. Nature Reviews Endocrinology, 2020; 16(1): 17–29.
LIM H, et al. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. Jama, 2017; 317(13): 1338–48.
LIRA RB, et al. Evolution in the profile of thyroid cancer cases treated in an oncology reference service: what changed in the last 20 years. Revista do Colégio Brasileiro de Cirurgiões, 2014; 41: 320–4.
MILLER KD, et al. Cancer statistics for adolescents and young adults, 2020. CA: a cancer journal for clinicians, 2020; 70(6): 443–59.
MIRANDA-FILHO A, et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. The lancet Diabetes & endocrinology, 2021; 9(4): 225–34.
MOON WJ, et al. Ultrasonography and the Ultrasound-Based Management of Thyroid Nodules: Consensus Statement and Recommendations. Thyroid, 2018; 28(4): 485–486.
NAOUM PC e NAOUM FA. Marcadores Tumorais-Uma Revisão até 2018. Academia de Ciência e Tecnologia, 2018.
OROSCO RK, et al. Analysis of age and disease status as predictors of thyroid cancer-specific mortality using the Surveillance, Epidemiology, and End Results database. Thyroid, 2015; 25(1): 125-32.
PIZZATO M, et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. The Lancet Diabetes & Endocrinology, 2022; 10(4): 264–72.
SIEGEL RL, et al. Colorectal cancer statistics, 2020. CA: a cancer journal for clinicians. 2020; 70(3): 145–64.
TEIXEIRA JMP, et al. Qualidade de vida do doente portador de patologia oncológica da próstata. Rev Enf Ref., 2020; 1: e19063.
TOMEI S, et al. c-KIT receptor expression is strictly associated with the biological behaviour of thyroid nodules. Journal of translational medicine, 2012; 10(1): 1–9.
TRIMBOLI P, et al. Calcitonin measurement in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid cancer: a retrospective multicentre study. Clinical endocrinology, 2014; 80(1): 135–40.
TUTTLE RM. Câncer diferenciado de tireoide: visão geral do manejo . Disponível em: www.uptodate.com/contents/ Differentiated-tireoid-cancer-overview-of-management?source=search_result&search=Differentiated+tireoid+cancer%3A+overview+of+management&selectedTitle=1~150# H27. Acessado em: 29 de janeiro de 2023.
ULLMANN TM, et al. O status do seguro está associado à extensão do tratamento para pacientes com carcinoma papilífero de tireoide . Tireoide, 2019; 29 :1784–91.
WEIDERPASS E e STEWART BW. World câncer report. The International Agency for Research on Cancer (IARC). 2020.